EDN1 and myeloid sarcoma: The systemic hypertension seen in obese MS patients with IR is partly due to a vascular endothelial dysfunction with a decreased production of the vasodilator nitric oxide and an enhanced endothelin (ET-1) mediated vasoconstriction[5-7].